Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

National Parkinson Foundation Expands Expert Care Network

UC San Diego Health System Designated Center of Excellence 

MIAMI,FL — The Movement Disorder Center at UC San Diego Health System has been designated the 41st Center of Excellence in the National Parkinson Foundation’s (NPF) global network.  This competitive designation is the highest recognition offered by NPF to a Parkinson’s specialty clinic and represents the consensus of leaders in the field that the  multidisciplinary clinic at UC San Diego Health System is among the world’s leading centers for Parkinson’s research, outreach and care. 

NPF Centers of Excellence are designated after a rigorous application and peer-review process. NPF has created a network of the leading academic medical centers that leverage the interplay between cutting-edge research and exemplar patient-focused clinical care.  The Center of Excellence network is a proving ground for new therapies and care models through NPF’s largest grants program and targeted initiatives such as the Parkinson’s Outcomes Project. The network reflects NPF’s ongoing commitment to promoting greater access to expert care.

“It is an honor to continue my association with the National Parkinson Foundation.  The movement disorder program at UC San Diego was intentionally modeled after the Center of Excellence vision because of its comprehensive patient-centered focus,” said Irene Litvan, MD, Tasch Endowed Professor in Parkinson’s Disease Research and Director of the Movement Disorders Center at UC San Diego. “At UC San Diego, we are dedicated to transitioning scientific advances to our patients, and also providing our patients the opportunity to contribute to research and discovery.”

UC San Diego is a leader both scientifically and clinically in several priority areas for patients.  Cognition is a focus at the center, with an interdisciplinary team with deep experience in cognitive assessment and cognitive rehabilitation, based on the department’s pioneering work in Alzheimer’s disease.  The center leads in research to understand the cause of Parkinson’s, with strong programs in neuropathology and using stem cells to investigate gene-environment interactions that can lead to the disease.  The center is also working to make sure that the next generation of scientists carries on these efforts, with strong and well-integrated training and fellowship programs. UC San Diego is the 26th Center of Excellence to be added in the U.S., following Emory University in October 2014. 

“Dr. Litvan truly shares NPF’s vision for the integrated research and care enterprise, where patient-focused clinicians deliver the latest care and newest therapies.  Their clinic benefits from research into novel approaches that advance our knowledge and their research agenda reflects the priorities of patients and families,” said Peter Schmidt, PhD, NPF’s Vice President of Research and Professional Programs. 

NPF’s Center of Excellence network features world-renowned Parkinson’s specialists focused on reaching across patient and professional communities to change the course of Parkinson’s disease. The network serves more than 50,000 individuals diagnosed with Parkinson’s. In order to participate in the competitive designation process, centers must first meet strict criteria for research, comprehensive care, patient outreach services and professional education.  The NPF Center of Excellence network is widely credited with developing and promoting the modern Parkinson’s team model of care and ensuring patients the highest standards of care.

NPF brings all Centers of Excellence together annually to provide updates on care activities and research initiatives. Each NPF Center of Excellence must re-certify every four years in order to ensure that they maintain high standards of care. This process includes a review of achievements as well as a team-based peer evaluation including an on-site assessment.

About the UC San Diego Health System
UC San Diego Health System, the region's only academic health system, is consistently ranked #1 in the San Diego metropolitan area by U.S. News & World Report with national rankings in 11 specialties. The health system is also ranked by the Leapfrog Group as a Top Hospital and with an A Hospital Safety Score, placing it among the safest hospitals in the United States. UC San Diego Health System is comprised of UC San Diego Medical Center in Hillcrest and UC San Diego Thornton Hospital, Moores Cancer Center (one of only 41 National Cancer Institute-designated comprehensive cancer centers in the country), Shiley Eye Center, Sulpizio Cardiovascular Center and Jacobs Medical Center (opening 2016) in La Jolla, as well as other primary and specialty practices located throughout Southern California.

Wednesday, February 11, 2015
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.